Thromboembolic and hemorrhagic risks after vaccination against SARS-CoV-2: a systematic review and meta-analysis of randomized controlled trials
Abstract Background Thromboembolic and bleeding events after vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are major public concerns leading to vaccine hesitancy. Due to low incidence, an individual randomized controlled trial (RCT) is underpowered to determine whe...
Guardado en:
Autores principales: | Noppacharn Uaprasert, Krissana Panrong, Ponlapat Rojnuckarin, Thita Chiasakul |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/60d90bd8c2444aebb5c495d3a2b9c9c5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Patients with venous thromboembolism after spontaneous intracerebral hemorrhage: a review
por: Qiyan Cai, et al.
Publicado: (2021) -
Heritable Thrombophilia in Venous Thromboembolism in Northern Pakistan: A Cross-Sectional Study
por: Maria Khan, et al.
Publicado: (2021) -
Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance
por: Masarret Fazili, et al.
Publicado: (2020) -
Rivaroxaban in acute venous thromboembolism: UK prescribing experience
por: Victoria Speed, et al.
Publicado: (2021) -
IMMUNE THROMBOCYTOPENIA PURPURA FLARE POST SARS-COV-2 VACCINATION
por: Elrazi Ali, et al.
Publicado: (2021)